Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 53 of the 61 references it cites were found in a registry or an index; 29 of the 61 sources its claims cite were checked for support.

Efficacy in bowel movement and change of gut microbiota on adult functional constipation patients treated with probiotics-containing products: a systematic review and meta-analysis

Open access
Ding, Fei, Hu, Mengyang, Ding, Yifei, Meng, Yingying, Zhao, Yanchao · 2024 · BMJ Open

Abstract

Objectives: This study aimed to pool the efficacy in bowel movement and explore the change of gut microbiota on adult functional constipated patients after probiotics-containing products treatment. Design: Systematic review and meta-analysis. Data sources: PubMed, Cochrane Library for published studies and ClinicalTrials.gov for ‘grey’ researches were independently investigated for randomised controlled trials up to November 2022. Eligibility criteria, data extraction and synthesis: The intervention was probiotics-containing product, either probiotics or synbiotics, while the control was placebo. The risk of bias was conducted. The efficacy in bowel movement was indicated by stool frequency, stool consistency and Patient Assessment of Constipation Symptom (PAC-SYM), while the change of gut microbiota was reviewed through α diversity, β diversity, change/difference in relative abundance and so on. The subgroup analysis, sensitivity analysis and random-effect meta-regression were conducted to explore the heterogeneity. The Grading of Recommendations Assessment Development and Evaluation was conducted to grade the quality of evidence. Results: 17 studies, comprising 1256 participants, were included with perfect agreements between two researchers (kappa statistic=0.797). Compared with placebo, probiotics-containing products significantly increased the stool frequency (weighted mean difference, WMD 0.93, 95% CI 0.47 to 1.40, p=0.000, I ² =84.5%, ‘low’), improved the stool consistency (WMD 0.38, 95% CI 0.05 to 0.70, p=0.023, I²=81.6%, ‘very low’) and reduced the PAC-SYM (WMD −0.28, 95% CI: −0.45 to −0.11, p=0.001, I²=55.7%, ‘very low’). In subgroup analysis, synbiotics was superior to probiotics to increase stool frequency. Probiotics-containing products might not affect α or β diversity, but would increase the relative abundance of specific strain. Conclusions: Probiotics-containing products, significantly increased stool frequency, improved stool consistency, and alleviated functional constipation symptoms. They increased the relative abundance of specific strain. More high-quality head-to-head randomised controlled trials are needed.

Overview

CoChat Summary

TL;DR

In adults with functional constipation, probiotics-containing products (probiotics or synbiotics) significantly increased stool frequency, improved stool consistency, and reduced PAC-SYM scores compared with placebo. Gut microbiota α/β diversity was generally unchanged, but relative abundance of specific supplemented strains often increased.

Key findings

  • Across 17 RCTs and 1256 participants, probiotics-containing products increased stool frequency versus placebo (WMD 0.93, 95% CI 0.47 to 1.40, p=0.000, I²=84.5%, GRADE “low”).
  • They improved stool consistency (WMD 0.38, 95% CI 0.05 to 0.70, p=0.023, I²=81.6%, GRADE “very low”) and reduced PAC-SYM (WMD −0.28, 95% CI −0.45 to −0.11, p=0.001, I²=55.7%, GRADE “very low”).
  • Synbiotics were superior to probiotics for stool frequency (synbiotics WMD 1.25, 95% CI 0.59 to 1.90, p=0.000; probiotics WMD 0.83, 95% CI 0.26 to 1.41, p=0.005); multistrain formula also showed significant efficacy (WMD 1.38, 95% CI 0.94 to 1.82, p=0.000).
  • Qualitative review of 8 studies suggested probiotics-containing products might not affect α or β diversity, but often increased relative abundance of specific strains; one study found decreased OTUs and Chao1 in the experimental group.

Methods

  • Systematic review and meta-analysis of parallel or cross-over RCTs in adults with functional constipation; intervention was probiotics or synbiotics, control was placebo; outcomes included stool frequency, stool consistency, PAC-SYM, and gut microbiota change.
  • Searched PubMed, Cochrane Library, and ClinicalTrials.gov up to November 2022; 17 studies with 1256 participants were included, with agreement between reviewers (kappa=0.797); PROSPERO registration CRD42022381368.
  • Pooled continuous outcomes using WMD or SMD with random/fixed-effect models, assessed heterogeneity by I², and performed subgroup analysis, sensitivity analysis, random-effect meta-regression, and GRADE; microbiota changes were qualitatively summarized through α diversity, β diversity, and relative abundance.

Limitations

  • Stated: modest sample sizes and high heterogeneity may misestimate efficacy; lack of clear protocols increases possible publication bias; obesity and diet may affect gut microbiota but relevant data were often unavailable; no unified methodology for measuring microbiota effects; negative data are underreported.
  • Evident from text: stool frequency and consistency pooled results had high heterogeneity (I²=84.5% and 81.6%, respectively), and GRADE quality was “low” for stool frequency and “very low” for stool consistency and PAC-SYM.
  • Evident from text: quantitative syntheses relied on limited study numbers for stool consistency (6 studies) and PAC-SYM (5 studies), and microbiota conclusions came from qualitative review of 8 studies with varied sequencing and analysis methods.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2023-074557

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 PRISMA flow diagram. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
Figure 1 PRISMA flow diagram. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.CC BY-NC · PubMed Central
Figure 2 Pooled estimates of the efficacy of probiotics-containing products on FC. (A) Forest plot for data pooling of stool frequency, (B) Forest plot for data pooling of stool consistency, (C) Forest plot for data pooling of PAC-SYM. FC, functional constipation; PAC-SYM, Patient Assessment of Constipation Symptom.
Figure 2 Pooled estimates of the efficacy of probiotics-containing products on FC. (A) Forest plot for data pooling of stool frequency, (B) Forest plot for data pooling of stool consistency, (C) Forest plot for data pooling of PAC-SYM. FC, functional constipation; PAC-SYM, Patient Assessment of Constipation Symptom.CC BY-NC · PubMed Central
Figure 3 GRADE summary of pooled results. FC, functional constipation; GRADE, Grading of Recommendations Assessment Development and Evaluation; PAC-SYM, Patient Assessment of Constipation Symptom.
Figure 3 GRADE summary of pooled results. FC, functional constipation; GRADE, Grading of Recommendations Assessment Development and Evaluation; PAC-SYM, Patient Assessment of Constipation Symptom.CC BY-NC · PubMed Central

Verification

Claims the paper makes

17 Valid · 4 Not valid · 16 Not checked · 44 Own results and interpretations

33 more claims · 7 with their cited sources checked

Create a free account to see all 81 claims and to verify the 2 references still open.

See all claims — free account
  • Probably not a substantial claim. 26
  • It may state two separate claims as one. 25

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 61 references

Cited by

See all 22

Metadata

Authors
Ding, F., Hu, M., Ding, Y., Meng, Y., & Zhao, Y.
Affiliations
  • Yancheng Third People's Hospital (CN)
  • Huazhong University of Science and Technology (CN)
  • Department of Gastroenterology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
Corresponding author
  • Meng, Yingying
  • Zhao, Yanchao
Venue
BMJ Open
Publisher
BMJ
Published
2024-01
Volume
14
Issue
1
Pages
e074557
ISSN
2044-6055 (ISSN-L)
OpenAlex
W4390988255
Cited by
22
References
61
Citations by year
2026: 8 · 2025: 11 · 2024: 3
FWCI
2.25
Type
journal article
Language
en
Open access
Locations
  • BMJ Open (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
functional constipation, probiotics, synbiotics, gut microbiota, defecation, stool frequency, stool consistency, alpha diversity, beta diversity, adults
MeSH terms
Gastrointestinal Microbiome, Adult, Constipation, Defecation, Humans, Probiotics, Synbiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy in bowel movement and change of gut microbiota on adult functional constipation patients treated with probiotics-containing products: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1136/bmjopen-2023-074557
The paper
Ding, F., Hu, M., Ding, Y., Meng, Y., & Zhao, Y. (2024). Efficacy in bowel movement and change of gut microbiota on adult functional constipation patients treated with probiotics-containing products: a systematic review and meta-analysis. BMJ Open. https://doi.org/10.1136/bmjopen-2023-074557

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.